Bank of Montreal
JUNO

Bank of Montreal’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bank of Montreal’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,107
Closed -$325K – 4491
2017
Q4 		$325K Buy
7,107
+679
+11% +$33.9K ﹤0.01% 2485
2017
Q3 		$288K Buy
6,428
+480
+8% +$16.4K ﹤0.01% 2509
2017
Q2 		$178K Sell
5,948
-11,215
-65% -$277K ﹤0.01% 2711
2017
Q1 		$381K Buy
17,163
+9,884
+136% +$212K ﹤0.01% 2205
2016
Q4 		$146K Buy
7,279
+141
+2% +$3.45K ﹤0.01% 2653
2016
Q3 		$214K Buy
7,138
+7,100
+18,684% +$221K ﹤0.01% 2441
2016
Q2 		$1K Sell
38
-10,662
-100% -$443K ﹤0.01% 4033
2016
Q1 		$408K Buy
10,700
+9,800
+1,089% +$341K ﹤0.01% 2124
2015
Q4 		$40K Buy
+900
New +$44.6K ﹤0.01% 3126

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Bank of Montreal's JUNO Position: Q1 2018 in Review

Bank of Montreal sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 7,107 shares — an estimated $325K sold.

Bank of Montreal first reported a position in JUNO in Q4 2015 and held it in 9 quarters. The position peaked at $408K in Q1 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Bank of Montreal reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of Montreal sold 7,107 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $325K.
  • Bank of Montreal first reported a position in Juno Therapeutics, Inc. in Q4 2015 and held it in 9 quarters.
  • Bank of Montreal's Juno Therapeutics, Inc. position peaked at $408K in Q1 2016.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.